These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38016679)

  • 21. Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
    Maeda H; Hayashida T; Watanuki R; Kikuchi M; Nakashoji A; Yokoe T; Seki T; Takahashi M; Kitagawa Y
    Breast Cancer; 2021 Mar; 28(2):398-404. PubMed ID: 33200381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of magnetic resonance computer-aided diagnosis for preoperatively determining invasive disease in ultrasonography-guided core needle biopsy-proven ductal carcinoma in situ.
    Ahn HS; Kim SM; Kim MS; Jang M; Yun B; Kang E; Kim EK; Park SY; Kim B
    Medicine (Baltimore); 2020 Jul; 99(31):e21257. PubMed ID: 32756104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative breast MRI positively impacts surgical outcomes of needle biopsy-diagnosed pure DCIS: a patient-matched analysis from the MIPA study.
    Cozzi A; Di Leo G; Houssami N; Gilbert FJ; Helbich TH; Álvarez Benito M; Balleyguier C; Bazzocchi M; Bult P; Calabrese M; Camps Herrero J; Cartia F; Cassano E; Clauser P; de Lima Docema MF; Depretto C; Dominelli V; Forrai G; Girometti R; Harms SE; Hilborne S; Ienzi R; Lobbes MBI; Losio C; Mann RM; Montemezzi S; Obdeijn IM; Aksoy Ozcan U; Pediconi F; Pinker K; Preibsch H; Raya Povedano JL; Rossi Saccarelli C; Sacchetto D; Scaperrotta GP; Schlooz M; Szabó BK; Taylor DB; Ulus SÖ; Van Goethem M; Veltman J; Weigel S; Wenkel E; Zuiani C; Sardanelli F
    Eur Radiol; 2024 Jun; 34(6):3970-3980. PubMed ID: 37999727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral and peritumoral radiomics based on dynamic contrast-enhanced MRI for preoperative prediction of intraductal component in invasive breast cancer.
    Xu H; Liu J; Chen Z; Wang C; Liu Y; Wang M; Zhou P; Luo H; Ren J
    Eur Radiol; 2022 Jul; 32(7):4845-4856. PubMed ID: 35079887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction Model For Extensive Ductal Carcinoma In Situ Around Early-Stage Invasive Breast Cancer.
    Knuttel FM; van der Velden BH; Loo CE; Elias SG; Wesseling J; van den Bosch MA; Gilhuijs KG
    Invest Radiol; 2016 Jul; 51(7):462-8. PubMed ID: 26863579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting underestimation of ductal carcinoma in situ: a comparison between radiomics and conventional approaches.
    Li J; Song Y; Xu S; Wang J; Huang H; Ma W; Jiang X; Wu Y; Cai H; Li L
    Int J Comput Assist Radiol Surg; 2019 Apr; 14(4):709-721. PubMed ID: 30569330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
    Chou SS; Romanoff J; Lehman CD; Khan SA; Carlos R; Badve SS; Xiao J; Corsetti RL; Javid SH; Spell DW; Han LK; Sabol JL; Bumberry JR; Gareen IF; Snyder BS; Gatsonis C; Wagner LI; Wolff AC; Miller KD; Sparano JA; Comstock CE; Rahbar H
    Radiology; 2021 Oct; 301(1):66-77. PubMed ID: 34342501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of an ultrafast breast MRI protocol in the differentiation of benign and malignant breast lesions.
    Ramli Hamid MT; Ab Mumin N; Wong YV; Chan WY; Rozalli FI; Rahmat K
    Clin Radiol; 2023 Jun; 78(6):444-450. PubMed ID: 37029001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High rate of postoperative upstaging of ductal carcinoma in situ when prioritizing ultrasound evaluation of mammography-detected lesions: a single-center retrospective cohort study.
    Hsieh YC; Lo C; Lee YH; Chien N; Lu TP; Tsai LW; Wang MY; Kuo WH; Chang YC; Huang CS
    World J Surg Oncol; 2023 Feb; 21(1):48. PubMed ID: 36804000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.
    Rahbar H; Partridge SC; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
    Radiology; 2012 May; 263(2):374-82. PubMed ID: 22517955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preoperative prediction of HER-2 expression status in breast cancer based on MRI radiomics model].
    Zhang Y; Huang H; Yin L; Wang ZX; Lu SY; Wang XX; Xiang LL; Zhang Q; Zhang JL; Shan XH
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):428-437. PubMed ID: 38742356
    [No Abstract]   [Full Text] [Related]  

  • 33. Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer.
    Yoo J; Kim BS; Yoon HJ
    Ann Nucl Med; 2018 Jun; 32(5):328-336. PubMed ID: 29556944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presurgical Upgrade Prediction of DCIS to Invasive Ductal Carcinoma Using Time-dependent Deep Learning Models with DCE MRI.
    Mayfield JD; Ataya D; Abdalah M; Stringfield O; Bui MM; Raghunand N; Niell B; El Naqa I
    Radiol Artif Intell; 2024 Sep; 6(5):e230348. PubMed ID: 38900042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic contrast-enhanced MRI reveals the extent and the microvascular pattern of breast ductal carcinoma in situ.
    Santamaría G; Velasco M; Farrús B; Caparrós FX; Fernández PL
    Breast J; 2013; 19(4):402-10. PubMed ID: 23758454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deep-learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy.
    Huang CY; Chang RF; Lin CY; Hsieh MS; Liao PC; Wang YJ; Kao YC; Porta L; Lin PY; Lee CC; Lee YH
    Histopathology; 2024 May; 84(6):983-1002. PubMed ID: 38288642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study.
    Cui S; Tang T; Su Q; Wang Y; Shu Z; Yang W; Gong X
    Cancer Imaging; 2021 Mar; 21(1):26. PubMed ID: 33750453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Added Value of Breast MRI for Preoperative Diagnosis of Ductal Carcinoma In Situ: Diagnostic Performance on 362 Patients.
    Petrillo A; Fusco R; Petrillo M; Triunfo F; Filice S; Vallone P; Setola SV; Rubulotta M; Di Bonito M; Rinaldo M; D'Aiuto M; Brunetti A
    Clin Breast Cancer; 2017 Jun; 17(3):e127-e134. PubMed ID: 28111130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study.
    Tanaka K; Masuda N; Hayashi N; Sagara Y; Hara F; Kadoya T; Matsui A; Miyazaki C; Shien T; Tokunaga E; Hayashi T; Niikura N; Maeda S; Komoike Y; Bando H; Kanbayashi C; Iwata H
    Breast Cancer; 2021 Jul; 28(4):896-903. PubMed ID: 33599914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ipsilateral Recurrence of DCIS in Relation to Radiomics Features on Contrast Enhanced Breast MRI.
    Park GE; Kim SH; Lee EB; Nam Y; Sung W
    Tomography; 2022 Mar; 8(2):596-606. PubMed ID: 35314626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.